Singapore markets closed

Samsung Biologics Co.,Ltd. (207940.KS)

KSE - KSE Delayed price. Currency in KRW
Add to watchlist
791,000.00+6,000.00 (+0.76%)
At close: 03:30PM KST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
857,691,298
857,691,298
798,056,210
393,589,468
240,974,800
Depreciation & amortisation
489,781,995
489,781,995
308,264,321
161,788,650
143,688,005
Change in working capital
298,743,499
298,743,499
-263,485,267
-234,840,497
-203,534,827
Inventory
-273,895,973
-273,895,973
-179,912,330
-370,570,855
-184,885,326
Other working capital
560,903,858
560,903,858
-56,177,801
33,444,391
53,523,994
Other non-cash items
-15,215,398
-15,215,398
11,200,069
4,747,012
2,745,267
Net cash provided by operating activities
1,666,228,521
1,666,228,521
953,047,810
454,596,217
202,090,027
Cash flows from investing activities
Investments in property, plant and equipment
-1,105,324,663
-1,105,324,663
-1,009,225,611
-421,151,826
-148,566,033
Acquisitions, net
-18,101,000
-1,084,113,840
-1,097,331,081
-12,375,000
-
Purchases of investments
-7,849,562,951
-7,849,562,951
-12,428,052,730
-5,840,000,000
-4,380,167,483
Sales/maturities of investments
8,465,729,712
8,465,729,712
11,427,889,761
5,340,000,000
4,110,000,000
Other investing activities
0.26
0.26
178,518
-0.01
-
Net cash used for investing activities
-1,566,305,450
-1,566,305,450
-3,106,477,133
-933,489,191
-418,685,827
Net change in cash
-522,882,206
-522,882,206
843,409,187
18,560,263
-96,250,533
Cash at beginning of period
890,819,571
890,819,571
47,410,384
28,850,121
125,100,653
Cash at end of period
367,937,365
367,937,365
890,819,571
47,410,384
28,850,121
Free cash flow
Operating cash flow
1,666,228,521
1,666,228,521
953,047,810
454,596,217
202,090,027
Capital expenditure
-1,105,324,663
-1,105,324,663
-1,009,225,611
-421,151,826
-148,566,033
Free cash flow
560,903,858
560,903,858
-56,177,801
33,444,391
53,523,994